MOSCOW (MRC) -- British speciality chemicals group Croda will sell most of its performance technologies and industrial chemicals division to commodities group Cargill Inc in a USD1 billion deal, said Reuters.
The sale of the unit, which makes low-carbon, sustainable additives and materials used in applications from food packaging to medical kits and devices, follows a strategic review as Croda shifts focus to its life sciences and consumer businesses. "We will focus our capital and resources on delivering sustainable solutions and scaling our consumer, health and crop care technologies," CEO Steve Foots said in a statement.
In a separate statement, Cargill said the deal would help broaden its offerings to industrial manufacturers looking for sustainable options. Croda is selling the majority of the business for an enterprise value of 915 million euros ($1 billion) on a cash-free, debt-free basis, it said. The business raked in 470 million pounds (USD626 million) in revenue last year.
Shares in the company, of the year's best performers in the FTSE 100 index (.FTSE), were down 1.5% at 1120 GMT. Some investors expecting a higher price for the deal may have been disappointed, Hargreaves Lansdown analyst Susannah Streeter said. Croda has been focusing its performance tech division towards markets such as renewable technology and electric vehicles.
More recently, the Yorkshire-based company has been supplying vaccine delivery components to Pfizer (PFE.N) for its COVID-19 vaccine, which helped it boost overall sales projections.
As per MRC, Cargill Inc and Thailand’s PTT Global Chemical Pcl announced they will build a biopolymer production facility at a cost of more than USD600 million in Thailand. The plant will be built through their joint venture, NatureWorks, and will help meet increasing demand for sustainable materials, PTTGC said in a statement. The manufacturing complex will use about 110,000 tonnes of sugar annually from Thai farmers as a raw material and have an annual biopolymer capacity of 75,000 tonnes. Its products can be used to make hygiene masks, wiping cloths and food packaging. The new plant is due to begin operations in 2024.
It was reported earlier, Arkema announces the proposed divestment of its epoxides business to Cargill, a leader in agricultural products and services. With this project, Arkema is pursuing the repositioning of its portfolio on its core businesses. Arkema produces bio-based and specialty epoxides in Blooming Prairie (MN, USA), used as additives or intermediates in the manufacture of lubricants, plastic additives and a wide variety of other applications.
MRC